Revvity targets 2026 growth with multiomics, AI-powered base editing, NGS newborn screening, and immunotherapy advances.

Cell free RNA diagnostics market is projected to reach US$ 204.5 Mn by 2035, expanding at a CAGR of 14.5% from 2025 to 2035 ...

Cedars-Sinai scientists have created a new experimental drug called TY1 that helps the body repair damaged DNA and restore ...

Spatial RNA medicine combines transcriptomics and RNA therapeutics, mapping gene expression in tissues to enhance precision ...

A team from the Andalusian Center for Molecular Biology and Regenerative Medicine (CABIMER) has developed an innovative ...

From enzymes and lipid nanoparticles to large-scale process design, four global innovators redefine RNA-based medicine development and delivery.

The universal features that define genomic regions acting as replication origins remain unclear. In this study, we mapped a set of origins in Trypanosoma brucei using stranded short nascent strand ...

Computational biology expert Nadia Lanman helps cancer researchers find solutions in massive datasets generated through ...

New fixation method streamlines blood sample handling for translational research. SEATTLE, December 04, 2025--(BUSINESS WIRE)--Parse Biosciences, a leading provider of accessible ...

Twenty-five years ago, the release of the first complete Arabidopsis thaliana genome marked a pivotal turning point in plant ...

Human gene maps contain major blind spots because they were built largely from the DNA sequences of people with European ...